Last reviewed · How we verify
B7A- CS6-expressing ETEC challenge strain
At a glance
| Generic name | B7A- CS6-expressing ETEC challenge strain |
|---|---|
| Sponsor | Johns Hopkins Bloomberg School of Public Health |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Efficacy Study of IM Administered CssBA+dmLT Against Moderate-severe Diarrhea in Human Infection Model With ETEC Strain B7A in Healthy Adults (PHASE2)
- Efficacy of B7A BSIgG Against E. Coli Strain B7A Challenge (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: